US20190046407A1 - Spike port for medical solution bag assembly and related methods - Google Patents
Spike port for medical solution bag assembly and related methods Download PDFInfo
- Publication number
- US20190046407A1 US20190046407A1 US15/673,269 US201715673269A US2019046407A1 US 20190046407 A1 US20190046407 A1 US 20190046407A1 US 201715673269 A US201715673269 A US 201715673269A US 2019046407 A1 US2019046407 A1 US 2019046407A1
- Authority
- US
- United States
- Prior art keywords
- spike port
- tip
- zone
- spike
- mold
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 22
- 239000008155 medical solution Substances 0.000 title description 9
- 239000012528 membrane Substances 0.000 claims abstract description 45
- 238000007789 sealing Methods 0.000 claims abstract description 15
- 239000012530 fluid Substances 0.000 claims abstract description 8
- 238000002347 injection Methods 0.000 claims description 27
- 239000007924 injection Substances 0.000 claims description 27
- 239000000463 material Substances 0.000 claims description 27
- 238000001746 injection moulding Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- 230000001954 sterilising effect Effects 0.000 claims description 7
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 230000003746 surface roughness Effects 0.000 claims description 5
- 229920012485 Plasticized Polyvinyl chloride Polymers 0.000 claims description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 34
- 239000011780 sodium chloride Substances 0.000 description 31
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- 239000004800 polyvinyl chloride Substances 0.000 description 12
- 229920000915 polyvinyl chloride Polymers 0.000 description 11
- 238000001631 haemodialysis Methods 0.000 description 10
- 230000000322 hemodialysis Effects 0.000 description 10
- 230000037452 priming Effects 0.000 description 6
- 239000002904 solvent Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- 239000004803 Di-2ethylhexylphthalate Substances 0.000 description 2
- BJQHLKABXJIVAM-UHFFFAOYSA-N bis(2-ethylhexyl) phthalate Chemical compound CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCC(CC)CCCC BJQHLKABXJIVAM-UHFFFAOYSA-N 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- -1 polyethylene Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012421 spiking Methods 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000002617 apheresis Methods 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 238000002615 hemofiltration Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2089—Containers or vials which are to be joined to each other in order to mix their contents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3643—Priming, rinsing before or after use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
- A61J1/10—Bag-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1475—Inlet or outlet ports
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/20—Closure caps or plugs for connectors or open ends of tubes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/22—Valves or arrangement of valves
- A61M39/24—Check- or non-return valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/002—Packages specially adapted therefor, e.g. for syringes or needles, kits for diabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/1411—Drip chambers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/142—Pressure infusion, e.g. using pumps
- A61M5/14212—Pumping with an aspiration and an expulsion action
- A61M5/14216—Reciprocating piston type
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/162—Needle sets, i.e. connections by puncture between reservoir and tube ; Connections between reservoir and tube
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/16831—Monitoring, detecting, signalling or eliminating infusion flow anomalies
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/0046—Details relating to the filling pattern or flow paths or flow characteristics of moulding material in the mould cavity
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/17—Component parts, details or accessories; Auxiliary operations
- B29C45/26—Moulds
- B29C45/27—Sprue channels ; Runner channels or runner nozzles
- B29C45/2701—Details not specific to hot or cold runner channels
- B29C45/2708—Gates
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/17—Component parts, details or accessories; Auxiliary operations
- B29C45/46—Means for plasticising or homogenising the moulding material or forcing it into the mould
- B29C45/56—Means for plasticising or homogenising the moulding material or forcing it into the mould using mould parts movable during or after injection, e.g. injection-compression moulding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/1462—Containers with provisions for hanging, e.g. integral adaptations of the container
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/14—Details; Accessories therefor
- A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
- A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
- A61J1/2006—Piercing means
- A61J1/201—Piercing means having one piercing end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/10—Tube connectors; Tube couplings
- A61M2039/1061—Break-apart tubing connectors or couplings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
- A61M2205/507—Head Mounted Displays [HMD]
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C45/00—Injection moulding, i.e. forcing the required volume of moulding material through a nozzle into a closed mould; Apparatus therefor
- B29C45/17—Component parts, details or accessories; Auxiliary operations
- B29C45/26—Moulds
- B29C45/27—Sprue channels ; Runner channels or runner nozzles
- B29C2045/279—Controlling the flow of material of two or more nozzles or gates to a single mould cavity
Definitions
- This specification relates generally to spike ports for medical solution bag assemblies and related methods.
- a spike port is often times connected to a medical solution bag as part of the bag closure.
- a clinician typically removes a cover from the spike port and then inserts a spike into the spike port to break a barrier and provide access to the medical solution within the bag.
- a molded spike port in one aspect, includes a first portion defining a first chamber and a plug disposed in the first chamber. The plug is configured to form a seal with the first portion.
- the molded spike port also includes a second portion defining a second chamber, the second portion including a sealing ring configured to seal the spike port to a spike.
- the molded spike port also includes a tip configured to be inserted into a fluid bag, the tip including a membrane and a wall between the first portion and the second portion. The wall is configured to break when the first portion is twisted relative to the second portion.
- Implementations can include one or more of the following features.
- the membrane has a thickness of 0.3 mm to 0.5 mm.
- the sealing ring is configured to seal spikes of multiple configurations.
- one of the configurations is ISO-compliant and another of the configurations is non-ISO compliant.
- the sealing ring has an inner diameter of 4.8 mm to 5.0 mm.
- the tip of the spike port includes a smooth outer surface configured to seal the tip of the spike port to the fluid bag via heat sterilization.
- the smooth outer surface has a surface roughness of 0.56 ⁇ m.
- the plug is interference fit with the first chamber.
- the wall comprises a thinned portion with a wall thickness that is thinner than a remainder of the wall.
- the spike port is made from plasticized polyvinyl chloride.
- a method of manufacturing a molded spike port includes injection molding a spike port.
- the method includes flowing a material through two injection mold gates on opposing sides of a tip zone of a spike port mold, the injection mold gates being positioned a predetermined length from an end of the tip of the mold.
- the method also includes filling a membrane zone of a mold such that material from the two injection mold gates meets in the membrane zone.
- the method also includes filling a tip zone of a spike port mold with material and compressing the material in the membrane zone to form a membrane with a predetermined membrane thickness.
- Implementations can include one or more of the following features.
- the predetermined membrane thickness is 0.3 mm to 0.5 mm.
- the injection mold gates are positioned approximately 8.3 mm to 8.7 mm from the end of the tip zone of the mold.
- a knit line is formed in the membrane zone when the material from the two injection mold gates meets in the membrane zone.
- filling the tip zone of a spike port mold creates a spike port tip with a smooth outer surface.
- the smooth outer surface has a surface roughness of 0.56 ⁇ m.
- the method includes filling a first portion zone of a spike port mold and a second portion zone of a spike port mold such that the first portion and the second portion are connected at a thinned portion.
- the method includes filling a first portion zone of a spike port mold and a second portion zone of a spike port mold such that the second portion and the tip are connected at a distance further from the end of the tip zone of the mold than the two injection mold gates.
- a hydraulic cylinder compresses the material in the membrane zone to the predetermined thickness.
- Implementations can include one or more of the following advantages.
- the molded spike port is manufactured using a two-step injection molding process that avoids producing a knit line on the exterior of the tip of the second portion of the molded spike port or results in a knit line of negligible size.
- a knit line is produced during manufacturing where at least two flow fronts meet and the material in the flow fronts does not meld, or “knit” together, completely when meeting. Because there is no knit line or a knit line of a negligible size, the molded spike port can be attached to a saline bag without the use of a solvent. The absence of a knit line on the exterior surface also decreases the likelihood of contamination of the saline solution inside the bag. Additionally, the manufacturing process repeatably creates uniform molded spike ports, reducing failures in attaching the molded spike ports to saline bags and in inserting spikes into the molded spike ports.
- the molded spike port is flexible and able to be used with ISO-compliant and non-ISO-compliant spikes.
- the molded spike port includes a plug disposed in the first portion of the spike port.
- the plug provides structural support to the first portion of the spike port which is removable. The structural support in the first portion of the spike port minimizes deformation of the channel in the spike port where the spike is inserted.
- the plug is positioned within the first portion of the spike port with an interference fit to provide a seal. Therefore, the plug does not need to be welded in place in the first portion of the spike port, which is advantageous because welding can cause warping of the spike port.
- FIG. 1 is a schematic of a hemodialysis system configured for a priming procedure during which a saline bag assembly with a spike port is connected to a blood line set, which is operatively connected to a hemodialysis machine.
- FIGS. 2A and 2B are schematics of the saline bag assembly of FIG. 1 with the spike port closure in a closed state before connection of the blood line set and in an open state after the connection of the blood line set, respectively.
- FIGS. 3A, 3 B, and 3 C are front, side, and top views, respectively, of the spike port of the saline bag assembly of FIGS. 2A and 2B .
- FIG. 4 is an enlarged view of region 4 of a wall of the molded spike port in FIGS. 3A-3C .
- FIGS. 5A-5B schematically represent a manufacturing process for making the molded spike port of FIGS. 3A-3C .
- hemodialysis a patient's blood and a fluid (e.g., a dialysis solution or dialysate) pass through a dialyzer of a dialysis machine.
- a semi-permeable membrane in the dialyzer separates the blood from the dialysate within the dialyzer and allows diffusion and osmosis exchanges between the dialysate and the blood stream. These exchanges across the membrane remove waste products, including solutes like urea and creatinine, from the blood. These exchanges also regulate the levels of other substances, such as sodium and water, in the blood. In this way, the dialysis machine acts as an artificial kidney for cleansing the blood.
- a hemodialysis system 100 includes a hemodialysis machine 102 to which a blood line set including an arterial line 104 and a venous line 106 is connected. Before connecting the arterial line 104 and the venous line 106 to a patient, the hemodialysis machine is typically primed with a priming solution, such as saline, to remove air from a dialyzer 108 as well as other components of the blood line set.
- FIG. 1 shows the hemodialysis system 100 in a priming configuration in which the arterial line 104 is connected to a saline bag 110 via a spike port 112 .
- the venous line 106 is connected to a waste container or drain 114 .
- a blood pump 116 is operated in a manner to force saline from the saline bag 110 through the arterial line 104 , the blood pump 116 , the dialyzer 108 , and the venous line 106 .
- the blood pump 116 is typically run for a set period or until a set volume of the saline has been pumped through the blood line set.
- a saline bag 110 has a spike port 112 closing the saline bag.
- the spike port 112 has a first portion 202 and a second portion 204 .
- the second portion 204 has a tip 206 which extends into an interior chamber of the saline bag 110 .
- the tip 206 and the second portion 204 of the spike port 112 are separated by a membrane 208 .
- the tip 206 of the spike port 112 is inserted into the saline bag 110 and then the saline bag assembly 200 is sterilized using an appropriate sterilization technique (e.g., heat sterilization).
- an appropriate sterilization technique e.g., heat sterilization
- a body of the saline bag 110 and the tip 206 are melted together and form a seal.
- the spike port 112 is manufactured such that there is substantially no knit line on the exterior of the tip 206 , which allows the saline bag 110 and the spike port 112 to form a non-leaking, sterile seal during heat sterilization.
- a solvent e.g. cyclohexane
- the smoother outer surface of the tip 206 allows this expensive and toxic step to be removed.
- the first portion 202 of the spike port 112 is twisted off and removed.
- the first portion 202 and the second portion 204 are separated by a wall 210 which is designed to tear at a set height defined by a thinned portion of the wall. Removing the first portion 202 from the second portion 204 exposes the membrane 208 between the tip 206 and the second portion 204 .
- a spike 212 is inserted through the membrane 208 to access saline solution inside the saline bag 110 .
- the spike 212 may be an ISO-compliant spike or a non-ISO compliant spike as the spike port 112 is formed from a flexible material and can interface with either spike type.
- the saline solution travels through the spike 212 into the arterial line 104 for priming of the blood line set before hemodialysis, as shown in FIG. 1 .
- a plug 300 is positioned in a first chamber 302 of the first portion 202 of the spike port 112 .
- the plug 300 is interference fit with a wall that defines the first chamber 302 such that the plug 300 seals the first chamber 302 .
- the plug 300 can seal the first chamber 302 without the use of welding, making the manufacturing process faster and less expensive.
- the plug 300 also provides structural stability to the first portion 202 of the spike port 112 . This increased structural stability allows removal of the first portion 202 from the second portion 204 with minimal deformation of the wall 210 and the second portion 204 into which a spike 212 will be inserted. Deformation of the wall 210 and/or the second portion 204 , especially a second chamber 304 in the second portion 204 , can increase the insertion force required to insert the spike 212 into the saline bag 110 .
- the second chamber 304 in the second portion 204 of the spike port 112 extends, along a length L 1 , which may be approximately 11.0 mm to 11.4 mm (e.g., approximately 11.2 mm), from the wall 210 separating the first portion 202 and the second portion 204 to the membrane 208 .
- the second chamber has a diameter D 1 , which may be approximately 5.2 mm to 5.6 mm (e.g., approximately 5.4 mm).
- the tip 206 of the spike port 112 has a diameter D 2 adjacent to the membrane 208 and a diameter D 3 at the end of the tip 206 .
- D 2 may be approximately 4.9 mm to 5.3 mm (e.g., approximately 5.1 mm), and D 3 may be approximately 5.0 mm to 5.4 mm (e.g., approximately 5.2 mm).
- the membrane 208 may have a thickness of approximately 0.3 mm to 0.5 mm (e.g., approximately 0.4 mm).
- the spike port 112 has a length L 2 , which may be approximately 29.5 mm to 30.5 mm (e.g., approximately 30 mm).
- the first portion 202 has an exterior diameter D 4 and the second portion 204 has an exterior diameter D 5 .
- D 4 may be approximately 8.1 mm to 8.5 mm (e.g., approximately 8.3 mm) and D 5 may be approximately 7.6 mm to 8.0 mm (e.g., approximately 7.8 mm).
- the wall 210 at its narrowest circumference, has a diameter D 6 , which may be approximately 6.3 mm to 6.7 mm (e.g., approximately 6.5 mm).
- the tip 206 of the spike port 112 has an exterior diameter D 7 , which may be approximately 6.8 mm to 7.2 mm (e.g., approximately 7.0 mm).
- a first injection mark 306 is visible on the outside of the tip 206 of the spike port 112 and corresponds to a position of an injection gate during the injection molding manufacturing process for making the spike port 112 .
- the first injection mark 306 is positioned along axis A and at a distance L 3 from the end of the spike port 112 .
- L 3 may be approximately 8.3 mm to 8.7 mm (e.g., approximately 8.5 mm).
- the injection molding process will be discussed below in relation to FIG. 5 .
- the spike port 112 may have a width W 1 , which may be approximately 24.0 mm to 25.0 mm (e.g., approximately 24.5 mm).
- a sealing ring 400 extends from the second portion 204 of the spike port 112 into the second chamber 304 .
- the sealing ring 400 Upon removal of the first portion 202 of the spike port 112 , and spiking the membrane 208 with a spike 212 , the sealing ring 400 surrounds and interfaces with the spike 212 to seal the spike 212 to the spike port 112 .
- the sealing ring 400 has an interior diameter, which may be approximately 4.8 mm to 5.0 mm (e.g., approximately 4.9 mm).
- the inner diameter of the sealing ring 400 is about 0.0 mm to 0.5 mm smaller than the outer diameter of an ISO-compliant spike.
- the flexibility of the sealing ring 400 and the second portion 204 of the spike port 112 allows the spike port 112 to be used with an ISO-compliant spike or a non-ISO compliant spike.
- the sealing ring 400 can interface and form a seal with either spike type.
- a mold 500 is used to form a spike port 112 during an injection molding process.
- a plasticized polyvinyl chloride (PVC) material is injected into the mold 500 .
- the positioning of injection gates 504 a and 504 b in the mold 500 directs the flow of the PVC material into different portions of the mold 500 at different times.
- the PVC material flows through runners 502 a and 502 b before reaching the injection gates 504 a and 504 b.
- the injection gates 504 a and 504 b are positioned in the mold such that, when forming the membrane 208 and the tip 206 of the spike port 112 , a membrane zone 508 of the mold 500 is filled with PVC material before a tip zone 506 of the mold.
- PVC material flows through the injection gates 504 a and 504 b and into the membrane zone 508 .
- a knit line 510 is produced.
- the knit line 510 corresponds approximately with axis B shown in FIG. 3C .
- the PVC material flows into the tip zone 506 of the mold 500 .
- substantially no knit line is created on the exterior of the tip 206 .
- the tip has a surface roughness (R a ) of 0.56 ⁇ m, which allows the tip 206 to be sealed to a body of a saline bag during a heat sterilization process without the use of a solvent.
- the tip 206 is moved to compress the PVC material in the membrane zone 508 of the mold 500 to the required membrane thickness, which may be approximately 0.3 mm to 0.5 mm (e.g., approximately 0.4 mm).
- the motion of the tip 206 to compress the membrane 208 to the required membrane thickness can be controlled by a hydraulic cylinder with magnetic sensors.
- spike ports of the embodiments shown and discussed above include spike ports connected to a saline bag for use in priming a hemodialysis machine
- spike ports may be used on bags for other types of fluids or uses.
- a spike port may be used to close a bag of dialysate or other medical solutions.
- a spike port may be used with a bag containing a medication, or a bag of another medical fluid, which may be directly administered to a patient.
- a saline bag with a spike port may be directly connected to a patient through an IV for rehydration.
- a saline bag may have one or more additional ports.
- a spike port may be connected to a saline bag with an additional infusion port which allows for the infusion of medications, vitamins, or other additives into the saline bag.
- a spike port may be used to access the infused solution inside of the bag.
- the medical solution bags and spike ports described herein can be used with other types of blood treatment systems, including peritoneal dialysis systems, hemofiltration systems, hemodiafiltration systems, apheresis systems, etc. Additionally, it should be understood that the medical solution bags and spike ports described herein can be used with any of various other medical treatment systems that do not relate to blood treatments.
- a spike port may be formed from PVC plasticized with DEHP or DEHP free, other materials may be substituted.
- a spike port may be formed from another plastic material, including polyethylene, polypropylene, and poly (ethylene-vinyl acetate) (PEVA).
- spike ports of the embodiments shown and discussed above are described as not requiring a solvent (e.g. cyclohexane) for assembly and sealing with a saline bag, a solvent may nonetheless be used to create and/or reinforce the seal.
- a solvent e.g. cyclohexane
- spike ports discussed above have been described as having a thinned wall portion to allow the first portion to be removed from the second portion, other techniques can be used to enable the removal of the first portion from the second portion.
- a spike port may have a pull off tab or pull off cover which may enable removing the first portion from the second portion.
- a knit line may be located in another area of the spike port that would not interfere with assembly and sealing the spike port to a saline bag.
- the location of the injection mold gates could be arranged so a knit line would form on the first portion of the spike port, which is removed before spiking.
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Pulmonology (AREA)
- Manufacturing & Machinery (AREA)
- Mechanical Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- External Artificial Organs (AREA)
Abstract
Description
- This specification relates generally to spike ports for medical solution bag assemblies and related methods.
- A spike port is often times connected to a medical solution bag as part of the bag closure. To use the medical solution in a treatment, a clinician typically removes a cover from the spike port and then inserts a spike into the spike port to break a barrier and provide access to the medical solution within the bag.
- In one aspect, a molded spike port includes a first portion defining a first chamber and a plug disposed in the first chamber. The plug is configured to form a seal with the first portion. The molded spike port also includes a second portion defining a second chamber, the second portion including a sealing ring configured to seal the spike port to a spike. The molded spike port also includes a tip configured to be inserted into a fluid bag, the tip including a membrane and a wall between the first portion and the second portion. The wall is configured to break when the first portion is twisted relative to the second portion.
- Implementations can include one or more of the following features.
- In some implementations, the membrane has a thickness of 0.3 mm to 0.5 mm.
- In some implementations, the sealing ring is configured to seal spikes of multiple configurations.
- In some implementations one of the configurations is ISO-compliant and another of the configurations is non-ISO compliant.
- In some implementations, the sealing ring has an inner diameter of 4.8 mm to 5.0 mm.
- In some implementations, the tip of the spike port includes a smooth outer surface configured to seal the tip of the spike port to the fluid bag via heat sterilization.
- In some implementations, the smooth outer surface has a surface roughness of 0.56 μm.
- In some implementations, the plug is interference fit with the first chamber.
- In some implementations, the wall comprises a thinned portion with a wall thickness that is thinner than a remainder of the wall.
- In some implementations, the spike port is made from plasticized polyvinyl chloride.
- In another aspect, a method of manufacturing a molded spike port includes injection molding a spike port. The method includes flowing a material through two injection mold gates on opposing sides of a tip zone of a spike port mold, the injection mold gates being positioned a predetermined length from an end of the tip of the mold. The method also includes filling a membrane zone of a mold such that material from the two injection mold gates meets in the membrane zone. The method also includes filling a tip zone of a spike port mold with material and compressing the material in the membrane zone to form a membrane with a predetermined membrane thickness.
- Implementations can include one or more of the following features.
- In some implementations, the predetermined membrane thickness is 0.3 mm to 0.5 mm.
- In some implementations, the injection mold gates are positioned approximately 8.3 mm to 8.7 mm from the end of the tip zone of the mold.
- In some implementations, a knit line is formed in the membrane zone when the material from the two injection mold gates meets in the membrane zone.
- In some implementations, filling the tip zone of a spike port mold creates a spike port tip with a smooth outer surface.
- In some implementations, the smooth outer surface has a surface roughness of 0.56 μm.
- In some implementations, the method includes filling a first portion zone of a spike port mold and a second portion zone of a spike port mold such that the first portion and the second portion are connected at a thinned portion.
- In some implementations, the method includes filling a first portion zone of a spike port mold and a second portion zone of a spike port mold such that the second portion and the tip are connected at a distance further from the end of the tip zone of the mold than the two injection mold gates.
- In some implementations, a hydraulic cylinder compresses the material in the membrane zone to the predetermined thickness.
- Implementations can include one or more of the following advantages.
- In certain implementations, the molded spike port is manufactured using a two-step injection molding process that avoids producing a knit line on the exterior of the tip of the second portion of the molded spike port or results in a knit line of negligible size. A knit line is produced during manufacturing where at least two flow fronts meet and the material in the flow fronts does not meld, or “knit” together, completely when meeting. Because there is no knit line or a knit line of a negligible size, the molded spike port can be attached to a saline bag without the use of a solvent. The absence of a knit line on the exterior surface also decreases the likelihood of contamination of the saline solution inside the bag. Additionally, the manufacturing process repeatably creates uniform molded spike ports, reducing failures in attaching the molded spike ports to saline bags and in inserting spikes into the molded spike ports.
- In certain implementations, the molded spike port is flexible and able to be used with ISO-compliant and non-ISO-compliant spikes.
- In certain implementations, the molded spike port includes a plug disposed in the first portion of the spike port. The plug provides structural support to the first portion of the spike port which is removable. The structural support in the first portion of the spike port minimizes deformation of the channel in the spike port where the spike is inserted.
- In certain implementations, the plug is positioned within the first portion of the spike port with an interference fit to provide a seal. Therefore, the plug does not need to be welded in place in the first portion of the spike port, which is advantageous because welding can cause warping of the spike port.
- Other aspects, features, and advantages will be apparent from the description and drawings, and from the claims.
-
FIG. 1 is a schematic of a hemodialysis system configured for a priming procedure during which a saline bag assembly with a spike port is connected to a blood line set, which is operatively connected to a hemodialysis machine. -
FIGS. 2A and 2B are schematics of the saline bag assembly ofFIG. 1 with the spike port closure in a closed state before connection of the blood line set and in an open state after the connection of the blood line set, respectively. -
FIGS. 3A, 3 B, and 3C are front, side, and top views, respectively, of the spike port of the saline bag assembly ofFIGS. 2A and 2B . -
FIG. 4 is an enlarged view ofregion 4 of a wall of the molded spike port inFIGS. 3A-3C . -
FIGS. 5A-5B schematically represent a manufacturing process for making the molded spike port ofFIGS. 3A-3C . - During hemodialysis (“HD”), a patient's blood and a fluid (e.g., a dialysis solution or dialysate) pass through a dialyzer of a dialysis machine. A semi-permeable membrane in the dialyzer separates the blood from the dialysate within the dialyzer and allows diffusion and osmosis exchanges between the dialysate and the blood stream. These exchanges across the membrane remove waste products, including solutes like urea and creatinine, from the blood. These exchanges also regulate the levels of other substances, such as sodium and water, in the blood. In this way, the dialysis machine acts as an artificial kidney for cleansing the blood.
- Referring to
FIG. 1 , ahemodialysis system 100 includes ahemodialysis machine 102 to which a blood line set including anarterial line 104 and avenous line 106 is connected. Before connecting thearterial line 104 and thevenous line 106 to a patient, the hemodialysis machine is typically primed with a priming solution, such as saline, to remove air from adialyzer 108 as well as other components of the blood line set.FIG. 1 shows thehemodialysis system 100 in a priming configuration in which thearterial line 104 is connected to asaline bag 110 via aspike port 112. Thevenous line 106 is connected to a waste container or drain 114. To carry out the priming procedure, ablood pump 116 is operated in a manner to force saline from thesaline bag 110 through thearterial line 104, theblood pump 116, thedialyzer 108, and thevenous line 106. Theblood pump 116 is typically run for a set period or until a set volume of the saline has been pumped through the blood line set. - Referring to
FIG. 2A , asaline bag 110 has aspike port 112 closing the saline bag. Thespike port 112 has afirst portion 202 and asecond portion 204. Thesecond portion 204 has atip 206 which extends into an interior chamber of thesaline bag 110. Thetip 206 and thesecond portion 204 of thespike port 112 are separated by amembrane 208. To connect thespike port 112 to the body of the saline bag, thetip 206 of thespike port 112 is inserted into thesaline bag 110 and then thesaline bag assembly 200 is sterilized using an appropriate sterilization technique (e.g., heat sterilization). For example, during the heat sterilization process, a body of thesaline bag 110 and thetip 206 are melted together and form a seal. Thespike port 112 is manufactured such that there is substantially no knit line on the exterior of thetip 206, which allows thesaline bag 110 and thespike port 112 to form a non-leaking, sterile seal during heat sterilization. Traditionally, a solvent (e.g. cyclohexane) would be required to attach and seal a port to a saline bag. However, the smoother outer surface of thetip 206, allows this expensive and toxic step to be removed. - To prepare to open the
saline bag 110, thefirst portion 202 of thespike port 112 is twisted off and removed. Thefirst portion 202 and thesecond portion 204 are separated by awall 210 which is designed to tear at a set height defined by a thinned portion of the wall. Removing thefirst portion 202 from thesecond portion 204 exposes themembrane 208 between thetip 206 and thesecond portion 204. Referring toFIG. 2B , aspike 212 is inserted through themembrane 208 to access saline solution inside thesaline bag 110. Thespike 212 may be an ISO-compliant spike or a non-ISO compliant spike as thespike port 112 is formed from a flexible material and can interface with either spike type. The saline solution travels through thespike 212 into thearterial line 104 for priming of the blood line set before hemodialysis, as shown inFIG. 1 . - Referring to
FIG. 3A , aplug 300 is positioned in afirst chamber 302 of thefirst portion 202 of thespike port 112. Theplug 300 is interference fit with a wall that defines thefirst chamber 302 such that theplug 300 seals thefirst chamber 302. Theplug 300 can seal thefirst chamber 302 without the use of welding, making the manufacturing process faster and less expensive. Theplug 300 also provides structural stability to thefirst portion 202 of thespike port 112. This increased structural stability allows removal of thefirst portion 202 from thesecond portion 204 with minimal deformation of thewall 210 and thesecond portion 204 into which aspike 212 will be inserted. Deformation of thewall 210 and/or thesecond portion 204, especially asecond chamber 304 in thesecond portion 204, can increase the insertion force required to insert thespike 212 into thesaline bag 110. - The
second chamber 304 in thesecond portion 204 of thespike port 112 extends, along a length L1, which may be approximately 11.0 mm to 11.4 mm (e.g., approximately 11.2 mm), from thewall 210 separating thefirst portion 202 and thesecond portion 204 to themembrane 208. The second chamber has a diameter D1, which may be approximately 5.2 mm to 5.6 mm (e.g., approximately 5.4 mm). Thetip 206 of thespike port 112 has a diameter D2 adjacent to themembrane 208 and a diameter D3 at the end of thetip 206. D2 may be approximately 4.9 mm to 5.3 mm (e.g., approximately 5.1 mm), and D3 may be approximately 5.0 mm to 5.4 mm (e.g., approximately 5.2 mm). Themembrane 208 may have a thickness of approximately 0.3 mm to 0.5 mm (e.g., approximately 0.4 mm). Thespike port 112 has a length L2, which may be approximately 29.5 mm to 30.5 mm (e.g., approximately 30 mm). - Turning to
FIG. 3B , thefirst portion 202 has an exterior diameter D4 and thesecond portion 204 has an exterior diameter D5. D4 may be approximately 8.1 mm to 8.5 mm (e.g., approximately 8.3 mm) and D5 may be approximately 7.6 mm to 8.0 mm (e.g., approximately 7.8 mm). Thewall 210, at its narrowest circumference, has a diameter D6, which may be approximately 6.3 mm to 6.7 mm (e.g., approximately 6.5 mm). Thetip 206 of thespike port 112 has an exterior diameter D7, which may be approximately 6.8 mm to 7.2 mm (e.g., approximately 7.0 mm). Afirst injection mark 306 is visible on the outside of thetip 206 of thespike port 112 and corresponds to a position of an injection gate during the injection molding manufacturing process for making thespike port 112. Thefirst injection mark 306 is positioned along axis A and at a distance L3 from the end of thespike port 112. L3 may be approximately 8.3 mm to 8.7 mm (e.g., approximately 8.5 mm). There is a second injection mark, also positioned along axis A and at a distance L3 from the end of thespike port 112, on the opposite side of thetip 206 of thespike port 112 from thefirst injection mark 306. The injection molding process will be discussed below in relation toFIG. 5 . - Referring to
FIG. 3C , thespike port 112 may have a width W1, which may be approximately 24.0 mm to 25.0 mm (e.g., approximately 24.5 mm). - Turning to
FIG. 4 , a sealingring 400 extends from thesecond portion 204 of thespike port 112 into thesecond chamber 304. Upon removal of thefirst portion 202 of thespike port 112, and spiking themembrane 208 with aspike 212, the sealingring 400 surrounds and interfaces with thespike 212 to seal thespike 212 to thespike port 112. The sealingring 400 has an interior diameter, which may be approximately 4.8 mm to 5.0 mm (e.g., approximately 4.9 mm). The inner diameter of the sealingring 400 is about 0.0 mm to 0.5 mm smaller than the outer diameter of an ISO-compliant spike. The flexibility of the sealingring 400 and thesecond portion 204 of thespike port 112 allows thespike port 112 to be used with an ISO-compliant spike or a non-ISO compliant spike. The sealingring 400 can interface and form a seal with either spike type. - Turning to
FIG. 5A , amold 500 is used to form aspike port 112 during an injection molding process. During the injection molding process, a plasticized polyvinyl chloride (PVC) material is injected into themold 500. The positioning ofinjection gates mold 500 directs the flow of the PVC material into different portions of themold 500 at different times. The PVC material flows throughrunners injection gates - Turning to
FIG. 5B , theinjection gates membrane 208 and thetip 206 of thespike port 112, amembrane zone 508 of themold 500 is filled with PVC material before atip zone 506 of the mold. In forming themembrane 208 in themembrane zone 508 of themold 500, PVC material flows through theinjection gates membrane zone 508. When the PVC material frominjection gate 504 a meets the PVC material frominjection gate 504 b, aknit line 510 is produced. Theknit line 510 corresponds approximately with axis B shown inFIG. 3C . - After forming the
membrane 208 inmembrane zone 508, the PVC material flows into thetip zone 506 of themold 500. As the PVC material frominjection gate 504 a has already met the PVC material frominjection gate 504 b in the membrane zone, substantially no knit line is created on the exterior of thetip 206. Because substantially no knit line is created on the exterior of thetip 206, the tip has a surface roughness (Ra) of 0.56 μm, which allows thetip 206 to be sealed to a body of a saline bag during a heat sterilization process without the use of a solvent. - At the end of the injection cycle, the
tip 206 is moved to compress the PVC material in themembrane zone 508 of themold 500 to the required membrane thickness, which may be approximately 0.3 mm to 0.5 mm (e.g., approximately 0.4 mm). The motion of thetip 206 to compress themembrane 208 to the required membrane thickness can be controlled by a hydraulic cylinder with magnetic sensors. - While the spike ports of the embodiments shown and discussed above include spike ports connected to a saline bag for use in priming a hemodialysis machine, spike ports may be used on bags for other types of fluids or uses. For example, a spike port may be used to close a bag of dialysate or other medical solutions. In another example, a spike port may be used with a bag containing a medication, or a bag of another medical fluid, which may be directly administered to a patient. For example, a saline bag with a spike port may be directly connected to a patient through an IV for rehydration.
- While the spike ports of the embodiments shown and discussed above appear as the only port on a saline bag, a saline bag may have one or more additional ports. For example, a spike port may be connected to a saline bag with an additional infusion port which allows for the infusion of medications, vitamins, or other additives into the saline bag. A spike port may be used to access the infused solution inside of the bag.
- While certain embodiments describe a medical solution bag used with a hemodialysis system, the medical solution bags and spike ports described herein can be used with other types of blood treatment systems, including peritoneal dialysis systems, hemofiltration systems, hemodiafiltration systems, apheresis systems, etc. Additionally, it should be understood that the medical solution bags and spike ports described herein can be used with any of various other medical treatment systems that do not relate to blood treatments.
- While the spike ports of the embodiments shown and discussed above are described as being formed from PVC plasticized with DEHP or DEHP free, other materials may be substituted. For example, a spike port may be formed from another plastic material, including polyethylene, polypropylene, and poly (ethylene-vinyl acetate) (PEVA).
- While the spike ports of the embodiments shown and discussed above are described as not requiring a solvent (e.g. cyclohexane) for assembly and sealing with a saline bag, a solvent may nonetheless be used to create and/or reinforce the seal.
- While the spike ports discussed above have been described as having a thinned wall portion to allow the first portion to be removed from the second portion, other techniques can be used to enable the removal of the first portion from the second portion. For example, a spike port may have a pull off tab or pull off cover which may enable removing the first portion from the second portion.
- While the spike ports discussed above have a knit line in the membrane, a knit line may be located in another area of the spike port that would not interfere with assembly and sealing the spike port to a saline bag. For example, the location of the injection mold gates could be arranged so a knit line would form on the first portion of the spike port, which is removed before spiking.
Claims (19)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/673,269 US20190046407A1 (en) | 2017-08-09 | 2017-08-09 | Spike port for medical solution bag assembly and related methods |
EP18762661.9A EP3634536A1 (en) | 2017-08-09 | 2018-08-01 | Spike port for medical solution bag assembly and related methods |
MX2020001462A MX2020001462A (en) | 2017-08-09 | 2018-08-01 | Spike port for medical solution bag assembly and related methods. |
CN201880051679.3A CN110997037A (en) | 2017-08-09 | 2018-08-01 | Spike port for medical solution bag assembly and related methods |
CA3070459A CA3070459A1 (en) | 2017-08-09 | 2018-08-01 | Spike port for medical solution bag assembly and related methods |
AU2018314212A AU2018314212A1 (en) | 2017-08-09 | 2018-08-01 | Spike port for medical solution bag assembly and related methods |
PCT/US2018/044754 WO2019032344A1 (en) | 2017-08-09 | 2018-08-01 | Spike port for medical solution bag assembly and related methods |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15/673,269 US20190046407A1 (en) | 2017-08-09 | 2017-08-09 | Spike port for medical solution bag assembly and related methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20190046407A1 true US20190046407A1 (en) | 2019-02-14 |
Family
ID=63449648
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/673,269 Abandoned US20190046407A1 (en) | 2017-08-09 | 2017-08-09 | Spike port for medical solution bag assembly and related methods |
Country Status (7)
Country | Link |
---|---|
US (1) | US20190046407A1 (en) |
EP (1) | EP3634536A1 (en) |
CN (1) | CN110997037A (en) |
AU (1) | AU2018314212A1 (en) |
CA (1) | CA3070459A1 (en) |
MX (1) | MX2020001462A (en) |
WO (1) | WO2019032344A1 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2388042A2 (en) * | 2010-05-21 | 2011-11-23 | Technoflex | Connector for a liquid circuit |
US20140299568A1 (en) * | 2011-12-15 | 2014-10-09 | Ge Healthcare As | Package |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1598777A (en) * | 1978-05-08 | 1981-09-23 | Pennwalt Corp | Aseptic storage container |
US4201209A (en) * | 1978-05-24 | 1980-05-06 | Leveen Harry H | Molded hypodermic plunger with integral shaft and elastomeric head |
US5137527A (en) * | 1990-09-20 | 1992-08-11 | Clintec Nutrition Co. | Enteral-specific spike/bag port system |
JP2955798B2 (en) * | 1992-04-09 | 1999-10-04 | ポリプラスチックス株式会社 | Injection molding method |
JP4035674B2 (en) * | 1997-12-03 | 2008-01-23 | ブリヂストンスポーツ株式会社 | Golf ball injection mold, golf ball injection molding method, and golf ball |
IT1391951B1 (en) * | 2008-11-18 | 2012-02-02 | Lucomed Spa | CONNECTION DEVICE WITH PERFORABLE BARRIER |
US9005181B2 (en) * | 2012-03-09 | 2015-04-14 | Fenwal, Inc. | Sterile openable access port and containers including the same |
-
2017
- 2017-08-09 US US15/673,269 patent/US20190046407A1/en not_active Abandoned
-
2018
- 2018-08-01 EP EP18762661.9A patent/EP3634536A1/en active Pending
- 2018-08-01 CA CA3070459A patent/CA3070459A1/en active Pending
- 2018-08-01 AU AU2018314212A patent/AU2018314212A1/en active Pending
- 2018-08-01 WO PCT/US2018/044754 patent/WO2019032344A1/en unknown
- 2018-08-01 MX MX2020001462A patent/MX2020001462A/en unknown
- 2018-08-01 CN CN201880051679.3A patent/CN110997037A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2388042A2 (en) * | 2010-05-21 | 2011-11-23 | Technoflex | Connector for a liquid circuit |
US20140299568A1 (en) * | 2011-12-15 | 2014-10-09 | Ge Healthcare As | Package |
Also Published As
Publication number | Publication date |
---|---|
WO2019032344A1 (en) | 2019-02-14 |
MX2020001462A (en) | 2020-03-20 |
EP3634536A1 (en) | 2020-04-15 |
AU2018314212A1 (en) | 2020-01-30 |
CN110997037A (en) | 2020-04-10 |
CA3070459A1 (en) | 2019-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5806296B2 (en) | Tube set with improved gate for vial connection | |
US6517508B1 (en) | Set for blood processing | |
JP6911212B2 (en) | Multipurpose cap for fluid ports on medical devices | |
TWI451886B (en) | Medical device | |
EP0568275B1 (en) | Blood air trap chamber | |
US8021319B2 (en) | Extracorporeal blood set | |
US4878516A (en) | Arrangement for peritoneal dialysis and connector therefore | |
EP2864208B1 (en) | Blow fill seal luer syringe | |
US9545470B2 (en) | Dialysis connector and cap compatible with gas sterilization | |
DE102009018664A1 (en) | External function device i.e. blood treatment cassette, for use in dialyzing device, has non-return valves, addition valves and single-needle blood valve that are integrated in housing body for controlling fluid passing via device | |
CN102341135B (en) | Dialysis machine, for the manifold of dialysis machine and method | |
EP2988796B1 (en) | Cassette module with integrated centrifugal pump unit | |
JPH0160260B2 (en) | ||
JP6711818B2 (en) | Device for connecting a pierceable vial to a container or fluid line to transfer the contents of the vial into the container or fluid line, a method for making such a connection and transfer, and the use of such a device | |
JPS6290171A (en) | Apparatus and method for injecting pharmacologically acceptable substance in patient | |
CN104321087A (en) | Disposable cassette with luer locks and method for packaging | |
US20190046407A1 (en) | Spike port for medical solution bag assembly and related methods | |
WO2018030354A1 (en) | Blood circuit adapter set and blood circuit | |
CN203370152U (en) | Self-sealing thrombus prevention venous indwelling needle | |
CN109310571B (en) | Kit for peritoneal dialysis | |
US20240350789A1 (en) | Access port member and method of manufacturing the same | |
US20240342457A1 (en) | Access port member and method of manufacturing the same | |
US20240207597A1 (en) | Vented medical fluid supply line cap, assembly and method therefor | |
JP3179399B2 (en) | Medical device having a branch and method for manufacturing the same | |
JPH07124249A (en) | Circuit for processing body liquid and its manufacture |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
AS | Assignment |
Owner name: FRESENIUS MEDICAL CARE HOLDINGS, INC., MASSACHUSET Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:RABIA, KAHINA;TRUONG, MAKENZIE;CHAU, CHRISTOPHER YIM;SIGNING DATES FROM 20170814 TO 20171111;REEL/FRAME:050673/0444 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |